全文获取类型
收费全文 | 1823篇 |
免费 | 124篇 |
国内免费 | 25篇 |
专业分类
儿科学 | 147篇 |
妇产科学 | 15篇 |
基础医学 | 179篇 |
口腔科学 | 67篇 |
临床医学 | 171篇 |
内科学 | 421篇 |
皮肤病学 | 43篇 |
神经病学 | 37篇 |
特种医学 | 331篇 |
外科学 | 96篇 |
综合类 | 31篇 |
预防医学 | 69篇 |
眼科学 | 19篇 |
药学 | 117篇 |
1篇 | |
中国医学 | 1篇 |
肿瘤学 | 227篇 |
出版年
2023年 | 2篇 |
2022年 | 5篇 |
2021年 | 19篇 |
2020年 | 10篇 |
2019年 | 13篇 |
2018年 | 27篇 |
2017年 | 24篇 |
2016年 | 28篇 |
2015年 | 36篇 |
2014年 | 40篇 |
2013年 | 60篇 |
2012年 | 38篇 |
2011年 | 34篇 |
2010年 | 49篇 |
2009年 | 97篇 |
2008年 | 37篇 |
2007年 | 62篇 |
2006年 | 70篇 |
2005年 | 51篇 |
2004年 | 43篇 |
2003年 | 58篇 |
2002年 | 24篇 |
2001年 | 33篇 |
2000年 | 32篇 |
1999年 | 39篇 |
1998年 | 104篇 |
1997年 | 119篇 |
1996年 | 114篇 |
1995年 | 82篇 |
1994年 | 82篇 |
1993年 | 99篇 |
1992年 | 17篇 |
1991年 | 17篇 |
1990年 | 18篇 |
1989年 | 47篇 |
1988年 | 40篇 |
1987年 | 30篇 |
1986年 | 33篇 |
1985年 | 33篇 |
1984年 | 21篇 |
1983年 | 20篇 |
1982年 | 26篇 |
1981年 | 36篇 |
1980年 | 24篇 |
1979年 | 12篇 |
1978年 | 12篇 |
1977年 | 25篇 |
1976年 | 22篇 |
1975年 | 6篇 |
1967年 | 1篇 |
排序方式: 共有1972条查询结果,搜索用时 250 毫秒
1.
Birth weight on 12,644 singleton infants from 6,196 sibships born in Maryland between 1980 and 1984 were used to estimate the effects of nine maternal and infant covariates on the sibship correlation in birth weight. Assuming a homogeneous correlation across all families, the estimated intraclass correlation was 0.4664 (+/- 0.0099). This high sibship correlation makes it possible to predict, with reasonable accuracy, the birth weight of a child given information on previous sibs, as well as covariates on the mother and/or infant pertinent to a given pregnancy. The reduction in variance associated with incorporating information on the nine covariates used here was approximately equal to that obtained by conditioning on a single previous sib. Testing for heterogeneity in correlation among different groups of families showed that a crude measure of parity (first live birth vs. other), time between births, mother's marital status, and maternal age at the birth of the last child significantly influenced the sibship correlation in birth weight. 相似文献
2.
ME BURGE AM JOSHUA CM McNEIL R HUI MJ BOYER R ABRAHAM 《Asia-Pacific Journal of Clinical Oncology》2005,1(1):47-52
Background: Pemetrexed and cisplatin have recently been shown to significantly improve survival compared with cisplatin alone. However, there are only limited data reflecting teaching hospital experience outside a clinical trial. Pemetrexed has only been available in Australia on a restricted basis since 2002. We reviewed our experience of patients treated on the Australian ‘Special Access Scheme’ at three major thoracic oncology units. Methods: Charts were reviewed for all patients enrolled on the scheme. Data was extracted on age, World Health Organization (WHO) performance status, histology, prior therapy, time from diagnosis to starting pemetrexed, chemotherapy (pemetrexed alone or with a platinum), cycle number, response rate, actuarial progression‐free and overall survival. Doses were cisplatin 75 mg/m2 or carboplatin AUC = 5 and pemetrexed 500 mg/m2 every 21 days. Results: 52 patients (32 male and 20 female) were reviewed. Median age was 58 years and 88% were WHO 0–1. Histology included 54% epithelial, 17% biphasic (epithelial and sarcomatoid) and 21% undefined. The median time from diagnosis to administration of pemetrexed was 145 days. Sixty‐five percent had minimal surgical intervention with video assisted thoracoscopy, pleurodesis and biopsy, while 19% had received prior palliative radiation. Seventy‐one percent were chemotherapy naïve, the remaining 29% having received previous platinum and/or gemcitabine regimens. Twenty‐three percent had pemetrexed alone, 35% in combination with carboplatin and 42% with cisplatin. The median number of cycles was 4 (range 1–13). The response rate was 33%. No toxicity was observed in 20% grade 3–4 toxicity in 10% (majority nausea/vomiting). The median progression‐free and overall survival times from starting pemetrexed were 184 days and 298 days, respectively. Conclusions: Pemetrexed‐based regimens are safe and effective in a community setting in malignant mesothelioma. 相似文献
3.
Cytoskeletal association of human alpha-interferon-receptor complexes in interferon-sensitive and -resistant lymphoblastoid cells. 总被引:6,自引:2,他引:4
下载免费PDF全文
![点击此处可从《Proceedings of the National Academy of Sciences of the United States of America》网站下载免费的PDF全文](/ch/ext_images/free.gif)
L M Pfeffer N Stebbing D B Donner 《Proceedings of the National Academy of Sciences of the United States of America》1987,84(10):3249-3253
Human Daudi lymphoblastoid cells, which are highly sensitive to the antiproliferative action of human leukocyte alpha-interferon (IFN-alpha), and IFN-resistant and IFN-sensitive Daudi subclones (Cl2 and Cl1, respectively), contain 2300 (Kd = 20 X 10(-12) M), 3000 (Kd = 45 X 10(-12) M), and 3700 (Kd = 52 X 10(-12) M) IFN-alpha binding sites per cell, respectively. Thus, these IFN-sensitive and IFN-resistant cells have similar numbers of high-affinity IFN-alpha receptors. IFN-receptor complexes that are insoluble in Triton X-100 accumulate in IFN-sensitive but not in IFN-resistant cells. The ligand-induced accumulation of Triton-insoluble complexes in IFN-sensitive cells was inhibited by cytochalasin B. This suggests that the solubility change of IFN-receptor complexes results from their interaction with the cytoskeletal matrix. The dissociation of IFN-alpha from IFN-sensitive and IFN-resistant cells can be resolved into fast and slow components. IFN-alpha dissociates more slowly from IFN-sensitive cells than from IFN-resistant cells. Very slow dissociation of IFN-alpha from Triton-insoluble complexes correlates with this difference. These observations suggest that IFN-receptor complexes become coupled to the cytoskeletal matrix in IFN-sensitive but not in IFN-resistant cells, and that such interaction is an important element in the mechanism of the antiproliferative action of IFN-alpha on Daudi cells. 相似文献
4.
CM Reid M. Nelson P. Beckinsale P. Ryan LMH Wing LJ Beilin MA Brown GLR Jennings CI Johnston J. Marley JJ McNeil TO Morgan J. Shaw ID Steven MJ West 《Clinical and experimental pharmacology & physiology》1997,24(5):370-373
1. The present study aimed to determine the feasibility of conducting a 5 year cardiovascular outcome trial of the treatment of 6000 elderly hypertensive patients in Australian general practices. 2. General practitioners (GPs) were invited to participate by mail and personal follow-up. Patient records were reviewed to identify subjects for a blood pressure (BP) screening programme. Blood pressure was measured on three occasions and eligible subjects were included if the average BP was 160 mmHg systolic or 90 mmHg diastolic if systolic BP was 140 mmHg. 3. Seven hundred and forty-one GPs were approached and 89 were enrolled in the study (12% of mail invites and 75% of those receiving a personal contact). In 16 practices where screening was completed, 82 000 records were reviewed to identify 4% patients eligible for screening. Twenty-two per cent of eligible subjects attended screening. Of 1938 subjects screened, 180 (9%) had BP 5=160/90 mmHg. Forty-seven percent of subjects (n = 916) were receiving antihypertensive therapy and 184 (20%) were withdrawn from therapy. One hundred and sixteen (63%) of these subjects had BP return to study entry levels within 6 weeks. Fifty-seven newly diagnosed and 81 previously treated subjects were randomized (7% of the screened population). 4. Based on the high participation rate of GPs, the response rate of patients to attend a BP screening programme and the 7% randomization to screening ratio for entry into the study, the ANBP2 pilot study has demonstrated that it is feasible to recruit subjects from Australian general practices to a cardiovascular outcome trial. 相似文献
5.
6.
7.
8.
9.
10.
Role of nitric oxide in relaxation of the longitudinal layer of rectal smooth muscle 总被引:2,自引:2,他引:0
Mr. John F. Stebbing M.A. F.R.C.S. Alison F. Brading Ph.D. Neil J. McC Mortensen M.D. F.R.C.S. 《Diseases of the colon and rectum》1997,40(6):706-710
PURPOSE: This study was designed to investigate the role of nitric oxide in neurogenic relaxation of the longitudinal layer
of human rectal smooth muscle. METHODS: Tissue was obtained from the mid rectum of patients undergoing anterior resection
for carcinoma. Adjacent strips of longitudinal muscle were dissected and mounted in organ baths for isometric tension recording.
In preliminary experiments to determine the response of strips to cholinergic, adrenergic, and potential excitatory agonists,
strips were superfused with standard Krebs solution (37±0.5°C; pH, 7.4±0.05). Investigation of inhibitory, nonadrenergic noncholinergic
responses required the addition of 3×10−6 M histamine to induce reproducible and stable tension for five-minute “test” periods, during which electrical field stimulation
(EFS) and additional drugs were applied. In these experiments, strips were superfused with Krebs solution that contained atropine
sulfate (3×10−6 M) and guanethidine (3×10−6 M). RESULTS: The response to cholinergic and adrenergic agonists was typical of nonsphincter specialized gastrointestinal
smooth muscle. EFS elicited frequency-dependent, neurogenic (tetrodotoxin-sensitive) relaxations of precontracted strips,
which were reduced in dose-dependent fashion by addition ofNω-nitro-l-arginine and restored by addition of 3×10
−4
M
l-arginine but not by
d-arginine. Addition of exogenous nitric oxide (sodium nitroprusside) mimicked the relaxant response induced by EFS. CONCLUSION:
Smooth muscle from the longitudinal layer of human rectum receives an intrinsic inhibitory innervation mediated by nitric
oxide.
Supported and financed by the Medical Research Council, United Kingdom.
John Stebbing is in receipt of a Medical Research Council Clinical Training Fellowship.
Read at the meeting of The American Society of Colon and Rectal Surgeons, Seattle, Washington, June 9 to 14, 1996. 相似文献